AI4Eyes Medical Technologies completed FDA establishment registration and device listing for its AI eye care platform and says it can now sell the platform in the United States. This is a registration and listing, not a 510(k) clearance or De Novo authorization.
Our readUS eye care practices can now buy the platform. The release body names no device class; the page description calls it a Class I, 510(k) exempt device, which would mean no FDA premarket review of its AI claims.